International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma (https://www.myeloma.org/imwg/consensus-allogenic-stem-cell-transplant-myeloma-patients)
This statement concludes that treating multiple myeloma (MM) patients with allogeneic stem-cell transplantation (Allo-SCT) is not more successful than autologous stem-cell transplantation. In addition, more guidelines are needed to be set in order to make Allo-SCT a better form of treatment.
Authors:
Lokhorst H, Einsele H, Vesole D, Bruno B, San Miguel J, Perez-Simon JA, Kroger N, Moreau P, Gahrton G, Gasparetto C, Giralt S, Bensinger W; International Myeloma Working Group.
Click here to view article: